Skip to main content
. 2021 Aug 5;26(10):e1730–e1741. doi: 10.1002/onco.13908

Table 3.

Univariable and multivariable Cox proportional hazard models for survival in the overall cohort

Variable n Events, n (%) Median, mo 5‐yr survival % (95% CI) Univariable model Multivariable model
Cox univariable hazard ratio (95% CI) Cox univariable, FDR‐p Cox multivariable hazard ratio, adjusted (95% CI) Cox multivariable likelihood ratio, FDR‐p (n = 24,493)
SES group <.0001 <.0001
Low 7,044 2,588 (37) 90.6 55.8 (54.4–57.2) 1.53 (1.43–1.63) 1.35 (1.26–1.46)
Mid‐low 8,877 3,025 (34) 117.5 59.3 (58.1–60.5) 1.36 (1.28–1.45) 1.29 (1.20–1.38)
Mid‐high 9,452 2,890 (31) NR 64.3 (63.1–65.4) 1.16 (1.09–1.23) 1.15 (1.07–1.23)
High 5,530 1,490 (27) NR 67.9 (66.4–69.3)
Age group, yr <.0001 <.0001
18–30 5,822 2,052 (35) 103.2 57.2 (55.7–58.8) 1.19 (1.14–1.25) 1.15 (1.09–1.21)
31–40 25,081 7,941 (32) 155.8 62.6 (61.9–63.3)
Sex <.0001 <.0001
Female 14,812 4,567 (31) NR 63.5 (62.6–64.4)
Male 16,091 5,426 (34) 120.1 59.8 (58.8–60.7) 1.15 (1.11–1.20) 1.18 (1.13–1.23)
Race <.0001 <.0001
White 24,039 7,549 (31) NR 62.9 (62.2–63.7)
Black 4,437 1,737 (39) 71.9 53.1 (51.3–54.8) 1.38 (1.31–1.45) 1.20 (1.13–1.27)
Other 2,064 593 (29) NR 64.0 (61.4–66.5) 0.97 (0.89–1.05) 0.93 (0.85–1.02)
Ethnicity .222 .0044
Non‐Hispanic 23,534
Hispanic 4,642 0.97 (0.92–1.02) 0.92 (0.86–0.97)
Stage at diagnosis <.0001 <.0001
I 4,125 329 (8) NR 92.0 (91.0–93.0)
II 5,570 716 (13) NR 85.9 (84.8–87.0) 1.68 (1.48–1.92) 1.63 (1.43–1.87)
III 10,435 2,528 (24) NR 72.0 (71.0–73.1) 3.46 (3.09–3.88) 3.54 (3.14–4.01)
IV 8,591 5,832 (68) 23.2 17.6 (16.6–18.6) 18.69 (16.72–20.90) 15.52 (13.76–17.52)
Grade <.0001 <.0001
Well/mod/none 24,886 7,291 (29) NR 64.9 (64.1–65.6)
Poorly diff 6,017 2,702 (45) 52.6 48.5 (47.1–50.0) 1.75 (1.67–1.82) 1.67 (1.59–1.75)
Side of tumor <.0001 <.0001
Left 22,210 6,922 (31) 146.3 63.0 (62.2–63.8)
Right 5,644 1,831 (32) NR 60.6 (59.1–62.1) 1.10 (1.05–1.16) 1.23 (1.16–1.30)
Other 3,049 1,240 (41) 71.1 52.8 (50.8–54.9) 1.49 (1.40–1.58) 1.12 (1.05–1.20)
Surgery of the primary tumor <.0001 <.0001
No 5,410 3,210 (59) 19.9 21.8 (20.4–23.2) 4.56 (4.37–4.76) 2.42 (2.29–2.54)
Yes 25,493 6,783 (27) NR 69.3 (68.6–70.0)
Chemotherapy <.0001 <.0001
Had chemo 20,931 7,599 (36) 93.2 56.9 (56.1–57.7) 1.58 (1.51–1.66) 0.83 (0.79–0.88)
No chemo 9,880 2,355 (24) NR 72.0 (71.0–73.0)
Comorbidity <.0001 <.0001
None 28,375 9,115 (32) 149.7 61.9 (61.2–62.5)
1 or more 2,528 878 (35) 108.1 58.1 (55.8–60.4) 1.17 (1.09–1.25) 1.17 (1.09–1.26)
Insurance statusa <.0001 N/A
Medicaid 4,787 1,897 (40) 62.0 50.5 (48.7– 52.2) 1.07 (0.995–1.15) N/A
Medicare 1,051 463 (44) 54.3 47.8 (44.1– 51.4) 1.17 (1.05–1.30) N/A
No insurance/unknow 3,239 1,268 (39) 69.3 52.5 (50.4–54.5) 1.61 (1.52–1.71) N/A
Private 21,024 6,068 (29) 66.2 (65.4–66.9) N/A
Area of Living <.0001 .0002
Metro 25,571 8,118 (32) 155.8 62.3 (61.6–63.0)
Urban/rural 4,574 1,645 (36) 101.1 57.2 (55.5–58.9) 1.18 (1.11–1.24) 1.12 (1.05–1.19)
a

Insurance status was considered as a mediator (not a confounder). Therefore, it was not included in the multivariable model to evaluate the effect of SES on survival.

Abbreviations: CI, confidence interval; NR, not reached; Poorly diff., poorly differentiated; mod., moderate differentiation; SES, socioeconomic status; Undiff., undifferentiated.